We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Derivation of Human Embryonic Stem Cells from Developing and Arrested Embryos

Read time: Less than a minute

The journal Stem Cells® has announced that scientists were able to derive pluripotent human embryonic stem cells (hESCs) from non-viable early human embryos.

The team, led by Professor Miodrag Stojkovic, derived hESCs using surplus and donated embryos that had stopped their cleavage.

The scientists demonstrated that these non-viable embryos could be used under suitable laboratory conditions for derivation of hESCs and for study of early human development.

This progress, published in Stem Cells®, encourages other scientists to perform hESC research using both viable and non-viable pre-implantation embryos in their attempt to understand and fight debilitating diseases. This article is freely available (Open Access) online

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.